Rifaximin

A synthetic rifamycin derivative and anti-bacterial agent that is used for the treatment of GASTROENTERITIS caused by ESCHERICHIA COLI INFECTIONS. It may also be used in the treatment of HEPATIC ENCEPHALOPATHY.

Year introduced: 2019 (1983)

PubMed search builder options

Subheadings:

Restrict to MeSH Major Topic.

Do not include MeSH terms found below this term in the MeSH hierarchy.

Tree Number(s): D03.633.400.811.850, D04.345.295.750.850

MeSH Unique ID: D000078262

Registry Number: L36O5T016N

Entry Terms:

• 4-Deoxy-4'-methylpyrido(1',2'-1,2)imidazo(5,4C)rifamycin
• L 105
• L-105
• L105
• Redactiv
• Xifaxan

Pharmacologic Action:

• Anti-Bacterial Agents
• Gastrointestinal Agents

All MeSH Categories
Chemicals and Drugs Category
Heterocyclic Compounds
Heterocyclic Compounds, Fused-Ring
Heterocyclic Compounds, 4 or More Rings
Rifamycins
Rifaximin

All MeSH Categories
Chemicals and Drugs Category
Polycyclic Compounds
Macrocyclic Compounds
Lactams, Macrocyclic
Rifamycins
Rifaximin